Cross Border Fundraising Gilde operates two specialized funds with a transatlantic footprint in Europe and North America and a focus on healthcare services, medtech, diagnostics, digital health, and therapeutics. This creates opportunities to offer cross-border fundraising support, investor relations, LP reporting, and regulatory guidance to streamline LP onboarding and co-investor participation across EU and US markets.

Portfolio Growth Partnerships Their portfolio includes Endovascular Engineering, Okami Medical, NIRx, Artinis, and Trompmedical, which points to opportunities to facilitate strategic partnerships, channel development, and commercial collaborations across hospitals, distributors and contract manufacturers, as well as potential co-development or licensing deals across Europe and North America.

Digital Transformation With a digital-first operating approach evidenced by DocuSign and cloud-based tools and a focus on medtech and digital health, there is a clear need for digital transformation services, including secure data rooms, streamlined due diligence, e-signature optimization, and data privacy/compliance solutions for portfolio companies and the fund's internal operations.

Exit Readiness Gilde's track record of acquisitions and exits suggests value in M&A advisory, integration planning, and value creation services to support portfolio exits or bolt-on acquisitions, leveraging their investor-exit orientation and strong deal execution history.

ESG Readiness Rising LP expectations around ESG and governance present an opportunity to provide ESG data collection, reporting, and governance services for the funds and portfolio companies to enhance transparency, sustainability credentials, and risk management.